These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27848224)

  • 21. The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.
    Adams BD; Parsons C; Slack FJ
    Expert Opin Ther Targets; 2016 Jun; 20(6):737-53. PubMed ID: 26652031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into lung development and diseases: the role of microRNAs.
    Johar D; Siragam V; Mahood TH; Keijzer R
    Biochem Cell Biol; 2015 Apr; 93(2):139-48. PubMed ID: 25563747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug target miRNAs: chances and challenges.
    Schmidt MF
    Trends Biotechnol; 2014 Nov; 32(11):578-585. PubMed ID: 25304465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?
    Dua K; Shukla SD; Tekade RK; Hansbro PM
    Drug Deliv Transl Res; 2017 Feb; 7(1):179-187. PubMed ID: 27924468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job.
    Chen SL; Zheng MH; Shi KQ; Yang T; Chen YP
    BioDrugs; 2013 Feb; 27(1):25-34. PubMed ID: 23329398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-Molecule Regulators of MicroRNAs in Biomedicine.
    Xia T; Li J; Cheng H; Zhang C; Zhang Y
    Drug Dev Res; 2015 Nov; 76(7):375-81. PubMed ID: 26450362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of microRNAs in the cardiovascular system.
    Scalbert E; Bril A
    Curr Opin Pharmacol; 2008 Apr; 8(2):181-8. PubMed ID: 18243792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice.
    Kheirolomoom A; Kim CW; Seo JW; Kumar S; Son DJ; Gagnon MK; Ingham ES; Ferrara KW; Jo H
    ACS Nano; 2015 Sep; 9(9):8885-97. PubMed ID: 26308181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. InflammamiRs in focus: Delivery strategies and therapeutic approaches.
    Akkaya-Ulum YZ; Sen B; Akbaba TH; Balci-Peynircioglu B
    FASEB J; 2024 Mar; 38(5):e23528. PubMed ID: 38441434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aptamer-MiRNA Conjugates for Cancer Cell-Targeted Delivery.
    Esposito CL; Catuogno S; de Franciscis V
    Methods Mol Biol; 2016; 1364():197-208. PubMed ID: 26472452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.
    Osaki M; Okada F; Ochiya T
    Ther Deliv; 2015 Mar; 6(3):323-37. PubMed ID: 25853308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs as therapeutic targets in atherosclerosis.
    Loyer X; Mallat Z; Boulanger CM; Tedgui A
    Expert Opin Ther Targets; 2015 Apr; 19(4):489-96. PubMed ID: 25464904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current progress on microRNAs-based therapeutics in neurodegenerative diseases.
    Pereira P; Queiroz JA; Figueiras A; Sousa F
    Wiley Interdiscip Rev RNA; 2017 May; 8(3):. PubMed ID: 27882692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting microRNAs As Cancer Therapeutics.
    Robb T; Reid G; Blenkiron C
    Target Oncol; 2017 Apr; 12(2):163-178. PubMed ID: 28138797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Not miR-ly small RNAs: big potential for microRNAs in therapy.
    Love TM; Moffett HF; Novina CD
    J Allergy Clin Immunol; 2008 Feb; 121(2):309-19. PubMed ID: 18269923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.